v3.25.2
Summary of Significant Accounting Policies - Correction of an Estimate (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Summary of Significant Accounting Policies            
Accrued expenses $ 2,783,149 $ 3,118,837   $ 2,783,149   $ 2,359,339
Total liabilities 3,931,696 3,848,187   3,931,696   4,848,412
Total liabilities and shareholders' equity 5,760,647 7,746,120   5,760,647   $ 8,966,483
Research and development 1,677,014 1,941,680 $ 501,158 3,618,694 $ 1,596,198  
Total operating expenses 2,763,879 3,026,508 1,744,675 5,790,387 3,861,766  
Loss from operations (2,763,879) (3,026,508) (1,744,675) (5,790,387) (3,861,766)  
Net loss applicable to common stockholders $ (2,701,976) $ (2,951,268) $ (1,644,502) $ (5,653,244) $ (3,559,829)  
Basic net loss per share (in Dollars per share) $ (0.82) $ (0.97) $ (1.31) $ (1.79) $ (3.71)  
Diluted net loss per share (in Dollars per share) $ (0.82) $ (0.97) $ (1.31) $ (1.79) $ (3.71)  
As previously reported            
Summary of Significant Accounting Policies            
Product Development Costs   $ 285,000        
Accrued expenses   3,404,332        
Total liabilities   4,133,682        
Total liabilities and shareholders' equity   7,746,120        
Research and development   2,227,175        
Total operating expenses   3,312,003        
Loss from operations   (3,312,003)        
Net loss applicable to common stockholders   $ (3,236,763)        
Basic net loss per share (in Dollars per share)   $ (1.06)        
Diluted net loss per share (in Dollars per share)   $ (1.06)        
Adjustments            
Summary of Significant Accounting Policies            
Accrued expenses   $ (285,495)        
Total liabilities   (285,495)        
Research and development   (285,495)        
Total operating expenses   (285,495)        
Loss from operations   285,495        
Net loss applicable to common stockholders   $ 285,495        
Basic net loss per share (in Dollars per share)   $ 0.09        
Diluted net loss per share (in Dollars per share)   $ 0.09